Expired Canadian patentCanada
Cultured cells from pancreatic islets
CA 2469209 C · Owner: Organogenesis Inc. · Inventors: Jin, Jianjian
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A cell composition of endocrine progenitor cells derived from mammalian pancreatic islet cells that can be transplanted into a diabetic patient such that the cells of the cell composition differentiates into functioning insulinproducing beta cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 4, 2002 and granted April 24, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 4, 2002
GrantedApril 24, 2012
Term endedDecember 4, 2022
Patent numberCA 2469209 C
Classification (IPC)C12N5/07 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.